537 related articles for article (PubMed ID: 18848473)
1. The TSC-mTOR signaling pathway regulates the innate inflammatory response.
Weichhart T; Costantino G; Poglitsch M; Rosner M; Zeyda M; Stuhlmeier KM; Kolbe T; Stulnig TM; Hörl WH; Hengstschläger M; Müller M; Säemann MD
Immunity; 2008 Oct; 29(4):565-77. PubMed ID: 18848473
[TBL] [Abstract][Full Text] [Related]
2. Essential role of tuberous sclerosis genes TSC1 and TSC2 in NF-kappaB activation and cell survival.
Ghosh S; Tergaonkar V; Rothlin CV; Correa RG; Bottero V; Bist P; Verma IM; Hunter T
Cancer Cell; 2006 Sep; 10(3):215-26. PubMed ID: 16959613
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models.
Lee L; Sudentas P; Donohue B; Asrican K; Worku A; Walker V; Sun Y; Schmidt K; Albert MS; El-Hashemite N; Lader AS; Onda H; Zhang H; Kwiatkowski DJ; Dabora SL
Genes Chromosomes Cancer; 2005 Mar; 42(3):213-27. PubMed ID: 15578690
[TBL] [Abstract][Full Text] [Related]
4. The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications.
Weichhart T; Säemann MD
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii70-4. PubMed ID: 19022819
[TBL] [Abstract][Full Text] [Related]
5. A versatile role of mammalian target of rapamycin in human dendritic cell function and differentiation.
Haidinger M; Poglitsch M; Geyeregger R; Kasturi S; Zeyda M; Zlabinger GJ; Pulendran B; Hörl WH; Säemann MD; Weichhart T
J Immunol; 2010 Oct; 185(7):3919-31. PubMed ID: 20805416
[TBL] [Abstract][Full Text] [Related]
6. Macrophage-induced tumor angiogenesis is regulated by the TSC2-mTOR pathway.
Chen W; Ma T; Shen XN; Xia XF; Xu GD; Bai XL; Liang TB
Cancer Res; 2012 Mar; 72(6):1363-72. PubMed ID: 22287548
[TBL] [Abstract][Full Text] [Related]
7. Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells.
Schmitz F; Heit A; Dreher S; Eisenächer K; Mages J; Haas T; Krug A; Janssen KP; Kirschning CJ; Wagner H
Eur J Immunol; 2008 Nov; 38(11):2981-92. PubMed ID: 18924132
[TBL] [Abstract][Full Text] [Related]
8. T-cell-specific deletion of gp130 renders the highly susceptible IL-10-deficient mouse resistant to intestinal nematode infection.
Fasnacht N; Greweling MC; Bollati-Fogolín M; Schippers A; Müller W
Eur J Immunol; 2009 Aug; 39(8):2173-83. PubMed ID: 19593768
[TBL] [Abstract][Full Text] [Related]
9. The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens.
Hsu YM; Zhang Y; You Y; Wang D; Li H; Duramad O; Qin XF; Dong C; Lin X
Nat Immunol; 2007 Feb; 8(2):198-205. PubMed ID: 17187069
[TBL] [Abstract][Full Text] [Related]
10. An immunomodulatory protein, Ling Zhi-8, induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and MAPK pathways.
Lin YL; Liang YC; Tseng YS; Huang HY; Chou SY; Hseu RS; Huang CT; Chiang BL
J Leukoc Biol; 2009 Oct; 86(4):877-89. PubMed ID: 19498044
[TBL] [Abstract][Full Text] [Related]
11. Echinacea-induced macrophage activation.
Sullivan AM; Laba JG; Moore JA; Lee TD
Immunopharmacol Immunotoxicol; 2008; 30(3):553-74. PubMed ID: 18618312
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells.
Weichhart T; Haidinger M; Katholnig K; Kopecky C; Poglitsch M; Lassnig C; Rosner M; Zlabinger GJ; Hengstschläger M; Müller M; Hörl WH; Säemann MD
Blood; 2011 Apr; 117(16):4273-83. PubMed ID: 21368289
[TBL] [Abstract][Full Text] [Related]
13. IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway.
Lee DF; Kuo HP; Chen CT; Hsu JM; Chou CK; Wei Y; Sun HL; Li LY; Ping B; Huang WC; He X; Hung JY; Lai CC; Ding Q; Su JL; Yang JY; Sahin AA; Hortobagyi GN; Tsai FJ; Tsai CH; Hung MC
Cell; 2007 Aug; 130(3):440-55. PubMed ID: 17693255
[TBL] [Abstract][Full Text] [Related]
14. STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria.
Samavati L; Rastogi R; Du W; Hüttemann M; Fite A; Franchi L
Mol Immunol; 2009 May; 46(8-9):1867-77. PubMed ID: 19299019
[TBL] [Abstract][Full Text] [Related]
15. Microarray analyses of the effects of NF-kappaB or PI3K pathway inhibitors on the LPS-induced gene expression profile in RAW264.7 cells: synergistic effects of rapamycin on LPS-induced MMP9-overexpression.
Mendes Sdos S; Candi A; Vansteenbrugge M; Pignon MR; Bult H; Boudjeltia KZ; Munaut C; Raes M
Cell Signal; 2009 Jul; 21(7):1109-22. PubMed ID: 19285553
[TBL] [Abstract][Full Text] [Related]
16. STAT3 and its activators in intestinal defense and mucosal homeostasis.
Hruz P; Dann SM; Eckmann L
Curr Opin Gastroenterol; 2010 Mar; 26(2):109-15. PubMed ID: 20040863
[TBL] [Abstract][Full Text] [Related]
17. Combination of a rapamycin analog (CCI-779) and interferon-gamma is more effective than single agents in treating a mouse model of tuberous sclerosis complex.
Lee L; Sudentas P; Dabora SL
Genes Chromosomes Cancer; 2006 Oct; 45(10):933-44. PubMed ID: 16845661
[TBL] [Abstract][Full Text] [Related]
18. Immune responses to Listeria monocytogenes.
Pamer EG
Nat Rev Immunol; 2004 Oct; 4(10):812-23. PubMed ID: 15459672
[TBL] [Abstract][Full Text] [Related]
19. Clemastine causes immune suppression through inhibition of extracellular signal-regulated kinase-dependent proinflammatory cytokines.
Johansen P; Weiss A; Bünter A; Waeckerle-Men Y; Fettelschoss A; Odermatt B; Kündig TM
J Allergy Clin Immunol; 2011 Dec; 128(6):1286-94. PubMed ID: 21807405
[TBL] [Abstract][Full Text] [Related]
20. Polybacterial immunomodulator Respivax restores the inductive function of innate immunity in patients with recurrent respiratory infections.
Nikolova M; Stankulova D; Taskov H; Nenkov P; Maximov V; Petrunov B
Int Immunopharmacol; 2009 Apr; 9(4):425-32. PubMed ID: 19186221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
